Use of anti-GP IIb-IIIa in acute thrombosis after intracoronary stent implantation

Catheterization and Cardiovascular Diagnosis

Volumn 43, Issue 1, 1998, Pages 105-107

  Henry, Patrick ^a   Boughalem, Kamel ^a   Rinaldi, Jean Paul ^b   Makowski, Serge ^a   Khalife, Kalife ^b   Guermonprez, Jean Léon ^a   Blanchard, Didier ^a  

^a HÔPITAL BROUSSAIS   (France)

^b Bon Secours Hospital   (France)

Author keywords

Antiplatelet therapy; GP IIb IIIa receptor inhibitor; Stent

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TICLOPIDINE;

ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; DRUG EFFICACY; FEMALE; HUMAN; IMPLANTATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSTOPERATIVE COMPLICATION; RESTENOSIS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY THROMBOSIS; CORONARY VESSELS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; PLATELET AGGREGATION INHIBITORS; RECURRENCE; STENTS;

EID: 0031963169     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199801)43:1<105::AID-CCD30>3.0.CO;2-M     Document Type: Article

References (8)

1. Jaffe EA, Weksler BB: Recovery of endothelial cells prostacyclin production after inhibition by low doses of aspirin. J Clin Invest 63:532-535, 1979.
2. Hall P, Nakamura S, Maiello L, Itoh A, Blengino S, Martini G, Ferrarro M, Colombo A: A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 93:215-222, 1996.
3. Shömig A, Neumann FJ, Kastrati A, Schulen H, Blasini R, Hadamitzki M, Walter H, Zitzmann-Roth AM, Richardt G, Alt E, Schmitt C, Ulm K: A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 334:1084-1089, 1996.
4. Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation 92:657-671, 1995.
5. Libby P: Molecular bases of the acute coronary syndromes. Circulation 91:2844-2850, 1995.
6. EPIC investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb-IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330:956-961, 1994.
7. Willerson JT: Inhibitors of platelet glycoprotein IIb/IIa receptors. Circulation 94:866-868, 1996.
8. Makkar RR, Eigler NL, Nakamura M, Litvak FI, Badimon L, Jordan R, Bramfitt J: Monoclonal antibody to IIb-IIIa receptor (m7E3) is highly effective in inhibiting acute stent thrombosis. Circulation 92:I685, 1995.